Dx Assays Opens R&D Lab As Singapore’s First Developer Of Molecular Diagnostic Assays
This article was originally published in PharmAsia News
Executive SummaryPERTH, Australia - Dx Assays, Singapore's first commercial developer of molecular diagnostic assays, opened its new R&D center in Singapore Sept. 8
You may also be interested in...
Dx assays Pte. Ltd. says its fee-for-service business model makes it a unique provider of companion diagnostics in a market set to boom globally as U.S. FDA and other regulators push for drug firms to develop diagnostics alongside drugs.